2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...
The US Food and Drug Administration (FDA) has revised its guidance for developers of vaccines against COVID-19 as regulators and health authorities assess the need to adjust vaccines so they remain ...
Antibodies are an important defense against SARS-CoV-2, but the virus continues to evolve ways to evade them. Now, researchers have mapped how antibodies target a key region of the virus's spike ...
Various national and international studies have examined the link between SARS-CoV-2 infection, COVID vaccination, and the development of systemic autoimmune diseases and other inflammatory conditions ...
Health and Me on MSN
XFG COVID variant: What India should watch as cases rise in UK and France
XFG, nicknamed ‘American COVID’ or Stratus, is a recombinant SARS-CoV-2 variant from the Omicron lineage. Experts said there ...
The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, ...
Researchers in Brazil have designed, synthesized and tested a new uracil-derived small molecule that shows measurable ...
XFG COVID cases are rising in England, but experts say the variant has not been shown to cause more severe disease.
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results